Avisi Tech is a startup based in the United States, most recent round Series A.
Avisi Tech is a company headquartered in the United States. Its most recent tracked round is Series A.
Avisi Tech develops an ultrathin nanotechnology-enabled glaucoma implant device called VisiPlate, designed to lower intraocular pressure in patients with open-angle glaucoma using advanced micro-fabrication techniques.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.